Proto5 Proto5

Proto5

9B02N019

    • $3.99
    • $3.99

Publisher Description

A scientist at a well-known university has been working for several years on the development of a drug that is a treatment for a particular type of cancer. He has successfully completed all pre-clinical trials and has filed an application for an investigational new drug. Once the application has been accepted by the Food and Drug Administration, the scientist plans to embark on a series of clinical trials. Although his work to this point has been financed by research grants and personal funds, he now needs to obtain more substantial financing from a venture capitalist. However, the scientist does not know what his fledgling company is worth.

GENRE
Business & Personal Finance
RELEASED
2002
November 29
LANGUAGE
EN
English
LENGTH
10
Pages
PUBLISHER
Richard Ivey School of Business Foundation
SELLER
Ivey Business School Foundation
SIZE
1.2
MB
LAB International Inc. LAB International Inc.
2009
The Future of Investment Management The Future of Investment Management
2018
Valuation of Corporate Growth Opportunities Valuation of Corporate Growth Opportunities
2020
Global Equity Selection Strategies Global Equity Selection Strategies
2014
Corporate Risk Management Corporate Risk Management
2019
Company Valuation and Bankruptcy Prediction Company Valuation and Bankruptcy Prediction
2013
Note on Contents of a Term Sheet Note on Contents of a Term Sheet
2002
Note on Valuing a Biotech Company Note on Valuing a Biotech Company
2008
Note on Private Company Valuation Note on Private Company Valuation
2001
North Village Capital Private Equity North Village Capital Private Equity
2010
Lululemon Athletica: Pitching an IPO Lululemon Athletica: Pitching an IPO
2011
Valuing Wal-Mart 2010 Valuing Wal-Mart 2010
2011